Images | Sources | Experiment + Assay | Phenotypes | Human Diseases | ||||
---|---|---|---|---|---|---|---|---|
fig.5.b;fig.S3.a
Shifley ET et al. (2012) |
Xla Wt + PD173074
NF35/36 (in situ hybridization) |
|
||||||
fig.5.b;fig.S3.a
Shifley ET et al. (2012) |
Xla Wt + PD173074
NF35/36 (in situ hybridization) |
|
||||||
fig.5.b;fig.S3.a
Shifley ET et al. (2012) |
Xla Wt + PD173074
NF35/36 (in situ hybridization) |
|
||||||
fig.2.p
Kenny AP et al. (2012) |
Xla Wt + bmp2 MO
NF37/38 (in situ hybridization) |
|
||||||
Fig. 4 (c2)
Deimling SJ and Drysdale TA (2011) |
Xla Wt + su5402 (@12.5)
NF32 (in situ hybridization) |
|
||||||
Fig. 4 (c3)
Deimling SJ and Drysdale TA (2011) |
Xla Wt + su5402 (@NF20)
NF32 (in situ hybridization) |
|
||||||
XB-PHENO-26973
Deimling SJ and Drysdale TA (2011) |
Xla Wt + su5402 (@NF24)
NF32 (in situ hybridization) |
|
||||||
fig.S7.b
Li Y et al. (2008) |
Xla Wt + wnt11b MO
NF35/36 (in situ hybridization) |
|